Intermittent fasting in breast cancer: a systematic review and critical update of available studies

M Anemoulis, A Vlastos, V Kachtsidis, SN Karras - Nutrients, 2023 - mdpi.com
Breast cancer (BC) is the most-frequent malignancy amongst women, whereas obesity and
excess caloric consumption increase the risk for developing the disease. The objective of …

Pancreatic cancer (PDAC): introduction of evidence-based complementary measures into integrative clinical management

V Jentzsch, J Davis, MBA Djamgoz - Cancers, 2020 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma is a devastating disease that is very
hard to treat. Here, we advance and evaluate the notion that the best possible management …

[HTML][HTML] Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth

L Yang, T TeSlaa, S Ng, M Nofal, L Wang, T Lan… - Med, 2022 - cell.com
Background Ketogenic diet is a potential means of augmenting cancer therapy. Here, we
explore ketone body metabolism and its interplay with chemotherapy in pancreatic cancer …

Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes

F Kalam, DL James, YR Li, MF Coleman… - JNCI …, 2023 - academic.oup.com
Intermittent fasting entails restricting food intake during specific times of day, days of the
week, religious practice, or surrounding clinically important events. Herein, the metabolic …

Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial

E Orgel, C Framson, R Buxton, J Kim, G Li… - Blood …, 2021 - ashpublications.org
Being overweight or obese (OW/OB) during B-cell acute lymphoblastic leukemia (B-ALL)
induction is associated with chemoresistance as quantified by minimal residual disease …

Effects of the periodic fasting-mimicking diet on health, lifespan, and multiple diseases: a narrative review and clinical implications

R Wang, X Lv, W Xu, X Li, X Tang, H Huang… - Nutrition …, 2024 - academic.oup.com
Dietary restriction and fasting have been recognized for their beneficial effects on health and
lifespan and their potential application in managing chronic metabolic diseases. However …

Unraveling the resistance of IGF-pathway inhibition in Ewing sarcoma

S de Groot, B Röttgering, H Gelderblom, H Pijl… - Cancers, 2020 - mdpi.com
Simple Summary The insulin-like growth factor-1 receptor (IGF1R) is a receptor commonly
overexpressed and overactivated in a variety of cancers, including Ewing sarcoma, and …

Impact of Diet Modifications on Body Weight, Body Composition, Treatment Outcomes, and Quality of Life During Primary Treatment for Breast Cancer: A Systematic …

K Chakos, L Pezley, A Bryner, O Czyzewski… - Nutrition …, 2024 - academic.oup.com
Context Breast cancer is a significant public health challenge, with 290 000 new cases
annually and significant healthcare costs. Treatment advancements have led to …

Mechanisms driving fasting-induced protection from genotoxic injury in the small intestine

K Deans-Fielder, T Wu, T Nguyen… - American Journal …, 2024 - journals.physiology.org
Genotoxic agents such as doxorubicin (DXR) can cause damage to the intestines that can
be ameliorated by fasting. How fasting is protective and the optimal timing of fasting and …

Calorie restriction in cancer patients undergoing chemotherapy: Facts, phantasy or misunderstanding

F Bozzetti - Clinical Nutrition, 2022 - Elsevier
Background & aims Experimental studies in cancer cell lines and tumour-bearing animals
support the concept that a short-period fasting could potentiate the effect of antineoplastic …